Jpmorgan Chase & CO Vor Biopharma Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 16,187 shares of VOR stock, worth $14,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,187
Previous 24,498
33.93%
Holding current value
$14,730
Previous $55,000
30.91%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VOR
# of Institutions
70Shares Held
29MCall Options Held
1.8KPut Options Held
100-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$5.88 Million0.57% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$5.79 Million5.32% of portfolio
-
Laurion Capital Management LP New York, NY3.18MShares$2.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$2.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$1.65 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $34.6M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...